Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol valerate pretreatment to regenerate endometrium and isolate endometrial stem cells in postmenopausal women
ACTRN12610000563066Phase 4Completed
- Sponsor
- Professor CAroline Gargett
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol valerate in pelvic organ prolapse (POP), sponsored by Professor CAroline Gargett. Primary endpoint: Isolation of endometrial mesenchymal stem cells. Started Jan 2011; status: completed.
02
Drugs
estradiol valerate
03
Conditions
pelvic organ prolapse (POP)
Beyond the preview
Go deeper on ACTRN12610000563066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000563066.